In a retrospective study, investigators found that radiofrequency ablation and parathyroidectomy for secondary hyperparathyroidism in patients on dialysis achieved intact parathyroid hormone levels in ...

There are two forms of hyperparathyroidism, primary hyperparathyroidism and secondary hyperparathyroidism. Mild cases of primary hyperparathyroidism may not require any treatment but secondary ...

Gastritis Predisposes Diabetes Patients to Metformin’s GI Effects If validated, new study findings may be used to develop a disease-specific patient-reported outcome measure that will inform SHPT ...

The US Food and Drug Administration (FDA) has approved the novel calcimimetic etelcalcetide (Parsabiv, Amgen) for the treatment of secondary hyperparathyroidism in adults on hemodialysis.

Please provide your email address to receive an email when new articles are posted on . A lower parathyroid hormone target treatment method was linked with reduced adjusted hazard of death. The ...

Doxercalciferol and calcitriol are equally effective at modulating serum parathyroid hormone levels, bone turnover and fibroblast growth factor 23 (FGF-23) in pediatric patients with secondary ...

Considerable advances have been made in the understanding of the pathogenesis and treatment of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD). These include the discovery that ...

A decision analysis model focusing on hospitalisation, survival rates and utilities for paricalcitol and calcitriol was used (Figure 1). Costs included yearly cost for medications and the costs ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 1b study ...

Please provide your email address to receive an email when new articles are posted on . Data released from the Dialysis Outcomes and Practice Patterns Study Program show use of the calcimimetic ...

However, despite suggestions that such secondarily stimulated hyperparathyroidism may become autonomous 12–14 convincing data regarding such a possibility are not available, owing to the great excess ...

The following organisations accepted the invitation to participate in this appraisal. They were invited to make submissions and comment on the draft scope, assessment report and Appraisal Consultation ...